4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-21-000394
Chief Financial Officer sold 762 shares at an average $525.23 ($400,222)
- Chief Financial Officer acquired 662 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hippel James · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-28 | Sale : show line 1 in the form | −100 | $525.18 | $52,518 | 10,755 | D |
| 2021-10-29 | Exercise or conversion : show line 2 in the form | +662 | $125.05 | $82,783 | 11,417 | D |
| 2021-10-29 | Sale : show line 3 in the form | −662 | $525.23 | $347,704 | 10,755 | D |
| Open-market sales · 762 sh · avg $525.23 · $400,222 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-29 | Exercise or conversion : show line 4 in the form Stock Options (Right to Buy) | −662 | 56,411 | D |
Loading xslF345X03/edgar.xml…